403
Sorry!!
Error! We're sorry, but the page you were looking for doesn't exist.
Knight Therapeutics Inc.
(MENAFN- Baystreet) 11:27 AM EST - Knight Therapeutics Inc.: Today reported financial results for its third quarter ended September 30, 2025. Revenues were $121,548, an increase of $29,285 or 32% over the same period in prior year. Net loss was $3,791, compared to a net income of $85 in the same period in prior year. Knight Therapeutics Inc.
shares T are trading up $0.24 at $6.08.
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research
More Story
Comments
No comment